Document:

PROMISSORY NOTE
                                ---------------

$500,000.00                                                       April 27, 2006
--------------------------------------------------------------------------------

     FOR VALUE RECEIVED, BRIDGETECH HOLDINGS INTERNATIONAL, INC. (the "Borrower"
or  the "Company") hereby promises to pay to the order of RICHARD D. PROPPER, MD
(the  "Lender"),  on  or before October 26, 2006 (the "Due Date"), the principal
sum  of  five  hundred thousand dollars ($500,000.00), together with interest on
the  unpaid  principal  balance  at the rate of eight (8%) percent per annum, as
provided  below.

     1.     Payment  Terms.    Principal  and Interest. All unpaid principal and
            --------------
accrued  interest shall be due and payable not later than the Due Date.   In the
event  that  the  Borrower  receives a total of $3,000,000 in financing (debt or
equity or a combination of the two) prior to the Due Date, then repayment of all
unpaid  principal  and  accrued  interest  shall  be  due within one week of the
receipt  of  such  financing.

     2.     Additional Consideration.   In addition to the amounts due to Lender
            ------------------------
from  Borrower  under  Section  1,  Borrower  shall  issue to Lender warrants to
purchase 200,000 shares of Borrower's Common Stock at an exercise price of $1.00
per  share  (the  "Warrants"), The Warrants shall have a term of five (5) years,
and  the  agreement  governing  the  Warrants  shall  contain  such terms as are
normally  contained in such an agreement, including a provision for the cashless
exercise  of  the  Warrants,

     2.  Events  of  Default.  The  entire unpaid principal amount of this Note,
         -------------------
together  with all accrued interest thereon, shall, at the option of the Lender,
forthwith  become  due and payable, without notice or demand of any kind, all of
which  are  hereby expressly waived, upon the occurrence of any of the following
events:

          (a)     if  there  is  a  default  in  the payment of the principal of
and/or  interest  on  the Note in accordance with the terms hereof or in the due
observance  or  performance  of  any  of the conditions, covenants or agreements
contained  herein;

          (b)     if the Company shall admit in writing its inability to pay its
debts  generally  as  they  become  due;

          (c)     if the Company shall become insolvent, or shall be adjudicated
bankrupt;

          (d)     if  bankruptcy,  insolvency,  arrangement, debt adjustment, or
receivership  proceedings,  in  which  the Company is alleged to be insolvent or
unable  to  pay  its debts as they mature, shall be instituted by or against the
Company,  and  the  Company  shall  consent  to the same or admit in writing the
material  allegations  of  the  petition  filed  in such proceedings; or if such
proceedings  shall  not  be  dismissed within 30 days after their institution or
within  such  additional  period  of  time  as  the  Company  shall

<PAGE>
reasonably  request,  provided  the  Company  is  diligently  and  in good faith
prosecuting  such  dismissal;

          (e)     if  the  Company  shall  make an assignment for the benefit of
creditors;

          (f)     if  there  is  a  material and adverse change in the Company's
financial  position  or  business  and  affairs;  or

          (g)     if  there is a default under any of the documents creating any
indebtedness  of  the Company and by reason of such default such indebtedness is
accelerated  or  the  Company  is required to make any payments other than those
which  would  have  been  due  in  the  absence  of  such  default.

     3.     Remedies.  In  case  any  one  or  more  of  the events specified in
            --------
Section  2  hereof shall have occurred and be continuing, the Lender may proceed
to  protect  and enforce its rights either by suit in equity and/or by action at
law, whether for the specific performance of any covenant or agreement contained
in this Note or in aid of the exercise of any power granted in this Note, or the
Company  may proceed to enforce the payment of all sums due upon this Note or to
enforce  any  other  legal  or  equitable  right  of  the  Company.

     4.     Payment  of  Costs and Expenses.    The Borrower shall pay all costs
            -------------------------------
and  expenses  (including,  without  limitation,  reasonable  attorneys'  fees)
incurred  by  the  Lender  in  order  to collect the amounts due hereunder or to
protect  its  interests  hereunder.

     5.     Waiver  of Presentment and Notice of Dishonor.  The Borrower and all
            --------------------------------------------
others  who  may  at  any  time  be  liable  hereon in any capacity, jointly and
severally,  waive  any  requirement of presentment, demand for payment, protest,
notice of dishonor, notice of acceleration, notice of protest, or further notice
or  demand  of  any  kind.

     6.     Notices.   All  notices, requests, consents and other communications
            ------
hereunder  to  any  party  shall  be  deemed  to be sufficient if contained in a
written  instrument  delivered  in  person  or  duly  sent by overnight courier,
facsimile  transmission  or  first  class  registered  or certified mail, return
receipt  requested,  postage prepaid, addressed to such party at the address set
forth  below  or such other address as may hereafter be designated in writing by
the  addressee  to  the  addressor  listing  all  parties:

               (a)  If to the Company, to:

                    Bridgetech Holdings International, Inc
                    402 W. Broadway,
                    26th Floor San Diego, CA 92101

                    f: 619-342-7498

                    Attn:  Michael D. Chermak

<PAGE>
               (b)  If to the Lender:

                    625 Broadway, Ste 1111
                    San Diego, CA 92101

                    f: 619

All  such  notices  and communications shall be deemed to have been given in the
case  of  (a)  facsimile transmission on the date sent, (b) personal delivery on
the  date  of such delivery, (c) overnight courier on the day following delivery
to  such  courier  and  (d)  mailing on the third day after the posting thereof.

     7.     Governing  Law.  This  Note  shall  be  governed by and construed in
            --------------
accordance  with  the  laws  of  the  State  of  California.

     8.     Binding  Effect:  Successor and Assigns.  This Note shall be binding
            ---------------------------------------
upon and inure to the benefit of and be enforceable by the respective successors
and  assigns  of  the parties hereto, provided that the Borrower may not sell or
assign  or  transfer  any  of  its  interest hereunder without the prior written
consent  of  the  Lender,  its  successors  or  assigns.

<PAGE>
     9.     Severability.  If  any  term,  condition,  or provision of this Note
             -----------
shall  be  held  to be invalid, illegal or unenforceable in any respect, then in
such event the remainder of this Note shall not be affected thereby and it shall
remain  in full force and effect except with respect to such term, condition, or
provision.

     10.     Amendments;  No  Waiver.  Failure  of the Lender to insist upon the
              ----------------------
strict  performance  of  any  term,  provision  or  covenant of this Note, or to
exercise any option or election conferred, shall not be deemed to be a waiver or
relinquishment  of  any  future  breach  of  any such term, covenant, condition,
election  or  option.  No  provision  of  this  Note  may be waived, modified or
discharged  orally,  by course of dealing or otherwise, without a writing signed
by  the  party  to  be  charged  with  such  waiver,  modification or discharge.

     IN  WITNESS  WHEREOF,  the Borrower has caused this Note to be executed and
delivered  by  its agent thereunto duly authorized, as of the date first written
above.

BRIDGETECH INTERNATIONAL HOLDINGS, INC.

By: /s/ Michael D. Chermak
   -----------------------------------
Name:  Michael D. Chermak
Title: Chairman and Chief ExecutiveEXHIBIT 10.26 AMCARE TERMINATION AGREEMENT

                              TERMINATION AGREEMENT

     This Termination Agreement (this "Agreement") is entered into as of this 5
day of April, 2007, by and between Bridgetech Holdings International, Inc., a
Delaware corporation, ("Amcare") and Bridgetech Holdings International, Inc.,
Delaware corporation ("Bridgetech"), collectively referred to hereinafter as the
"Parties" or individually as a "Party."

                                 R E C I T A L S

     WHEREAS, the Parties hereto desire to fully and finally terminate any and
all claims which may exist between them in connection with that certain joint
venture agreement entered into by the Parties and accepted by Bridgetech on or
about April 10, 2005 in which Amcare agreed to enter into a joint venture
agreement.

WHEREAS, AMCARE is an affiliate of Johns Hopkins International Medical
Laboratories;

WHEREAS, AMCARE is in the business of providing laboratory medicine and
pathology services in select global markets;

<PAGE>
WHEREAS, BRIDGETECH has developed a network of research and development,
manufacturing and distribution relationships in China;

WHEREAS, BRIDGETECH and AMCARE wish to form two joint ventures, each in
the form of a new corporation to be organized under the Delaware General
Corporation Law, for the respective purposes set forth below:

          a.   the development and operation of a clinical research organization
               within China (including Hong Kong) and Taiwan ("NEWCO1"),

          b.   the development and operation of clinical diagnostic anatomic and
               clinical pathology labs within China (including Hong Kong) and
               Taiwan ("NEWCO2");

WHEREAS, Newco1 and Newco2 will each be jointly owned by BRIDGETECH and
AMCARE in accordance with the provisions of this Agreement and the Related
Agreements, and will be operated in accordance with the terms of this Agreement
and the Related Agreements.

     1.     Termination of joint venture agreement.  The Parties agree to
terminate the joint venture agreement and any obligations, rights, or any other
similar interest each may have with respect to the other arising from the joint
venture agreement.

     2.     Release of Claims. In consideration of the mutual releases made
pursuant to this Agreement, the Parties, on behalf of themselves and their
agents, personal representatives, and assigns, past, present, and future, hereby
releases and forever discharges the other Party, any parent organization of the
other Party, any organization that controls, is controlled by, or is under
common control with the other Party, and each of their respective partners,
affiliates, associates, officers, directors, shareholders, managers, members,
employees, attorneys, accountants, insurers, agents, representatives,
predecessors, successors, and assigns, past, present, and future (collectively,
"Affiliates"), from any and all legal claims, demands, liens, agreements,
contracts, covenants, actions, suits, causes of action, obligations,
controversies, debts, costs, expenses, damages, judgments, orders, and
liabilities of whatever kind or nature in law, equity, or otherwise, whether now
known or unknown, suspected or unsuspected, concealed or hidden, of any kind or
nature whatsoever, which have ever existed or may have existed, or which do
exist or which hereafter can, shall, or may exist arising out of the Joint
venture agreement, occurring or existing at any time. Nothing in this section
shall release parties from obligations arising from other agreements between the
parties, including without limitation any strategic alliance agreements, joint
venture agreements, or engagement agreements.

     3.     Further Assurances. The Parties intend this Agreement to be a
complete and final settlement of the matters between them related to the joint
venture agreement. Accordingly, each Party agrees to execute such further
documents and to take such further actions as may be necessary or desirable to
finally and fully settle all such matters which have arisen or which may
subsequently arise between them.

     4.     Successors and Assigns. This Agreement shall be binding on and shall
inure to the benefit of the parties and their respective heirs, personal
representatives, successors, and assigns.

     5.     Amendments and Waivers. No amendment or waiver of any provision of
this Agreement shall be effective unless it is in writing and is signed by every
one of the parties hereto.

     6.     Notices. Any notice required hereunder to be given by either Party
shall be in writing and shall be delivered personally or sent by certified or
registered mail, postage prepaid, or by private courier, with written
verification of delivery, or by facsimile transmission to the other Party to the
address or telephone number set forth below or to such other address or
telephone number as either Party may designate from time to time according to
this provision. A notice delivered personally shall be effective upon receipt. A
notice sent by facsimile transmission shall be effective twenty-four hours after
the dispatch thereof. A notice delivered by mail or by private courier shall be
effective on the third day after the day of mailing.

<PAGE>
     To Bridgetech at:                    To AMCARE at:

402 West Broadway                   5801 Smith Avenue, Suite 305
26th Floor                          Baltimore, Maryland 21207
San Diego, CA  92101                USA
Attn: Michael Chermak               Attn: Mohan Chellappa
Phone 619-564-7100                  Phone: 410-735-6558
Fax: 619-564-1047                   Fax: 410-735-6552

     7.     Equitable Remedies. Each Party acknowledges and agrees that the
breach or threatened breach of certain provisions of this Agreement would cause
irreparable harm for which damages at law would be an inadequate remedy.
Accordingly, each Party hereby agrees that, in any such instance, the threatened
or injured Party shall be entitled to seek injunctive or other equitable relief
in addition to any other remedy to which he or it may be entitled, including
money damages.

     8.     Severability. If any provision of this Agreement is found to be
unenforceable by a court of competent jurisdiction, the remaining provisions
shall nevertheless remain in full force and effect.

     9.     Entire Agreement. This Agreement constitutes the full and complete
understanding of the Parties hereto with respect to the subject matter covered
herein and supersedes all prior oral or written understandings and agreements
with respect thereto. No modification or amendment to this Agreement shall be
effective unless it is contained in a written document that is signed by both
Parties.

     10.  Governing Law. This Agreement shall be governed and construed in
accordance with the laws of the State of StateplaceDelaware. The Parties further
agree that proper venue and jurisdiction for any dispute under this Agreement
shall lie with the courts in CityplaceSan Diego County, StateCalifornia.

     IN WITNESS WHEREOF, the Parties hereto have signed this Agreement by their
duly authorized representative as of the date first given above. This Agreement
may be executed in counterparts, all of which together shall constitute one and
the same instrument.

AMCARE LABS INTERNATIONAL, INC.          BRIDGETECH HOLDINGS INTERNATIONAL, INC.

/s/ Mohan Chellappa                      /s/ Michael Chermak
Mohan Chellappa, Pres                    Michael Chermak CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]